Compound Dossiers
Mechanisms, evidence summaries, safety signals, and primary sources for each peptide.
Citations Required Research Reference
Evidence-Based Peptide Research Hub
Fast access to primary literature, clear evidence summaries, and practical tools. Every claim is cited. No medical advice. Just the science.
42 Compounds
70 Studies Cited
16 FAQs Answered
Educational Content Only — This site provides research context and literature summaries.
It does not offer medical advice, dosing recommendations, or sourcing guidance.
Always consult qualified professionals.
What You'll Find
Literature Database
Searchable studies with type labels (RCT, animal, in vitro) and confidence tiers.
Evidence TieredReconstitution Calculator
Math-only concentration and volume conversions. You provide the target; we show the formula.
No RecommendationsFAQs & Primers
Quick answers with links to deeper explanations and the relevant compound pages.
Glossary
Clear definitions for PK/PD terms, receptor types, and research methodology.
Quick Search
Command palette (⌘K) for instant lookup across all compounds, FAQs, and terms.
Our Evidence Standards
Every claim is labeled by study type and confidence tier.
High Confidence
Multiple RCTs, systematic reviews, or meta-analyses with consistent findings.
Moderate Confidence
Limited RCTs, observational studies, or mixed evidence quality.
Low Confidence
Primarily in vitro, animal studies, case reports, or preliminary data.
What's New
View all content →Compound
Epitalon
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from pineal gland extract, studied over 25 years for geroprotective and neuroendocrine effects. Evidence includes in vitro, animal, and limited human studies showing antioxidant, neuro-protective, and antimutagenic effects. Not an approved medication.
Updated Jan 31, 2026
Compound
Retatrutide
An investigational triple agonist (GIP/GLP-1/glucagon) that achieved 28.7% weight loss in Phase 3 (TRIUMPH-4); currently in registrational trials with first successful results reported Dec 2025.
Updated Jan 25, 2026
Compound
5-amino-1MQ
A research small molecule commonly described as an NNMT inhibitor; human evidence and safety remain unclear.
Updated Jan 23, 2026
Compound
AOD-9604
A synthetic peptide derived from the C-terminal region of human growth hormone (hGH), discussed in metabolic/anti-obesity research with limited published clinical evidence.
Updated Jan 23, 2026
Compound
ARA 290
An erythropoietin-derived peptide (cibinetide) studied in tissue-protective signaling; early clinical data exist in select indications.
Updated Jan 23, 2026
Compound
Argireline
A cosmetic peptide (acetyl hexapeptide-8) used in topical formulations, with some randomized clinical evidence for wrinkle-related cosmetic endpoints.
Updated Jan 23, 2026